Current Alzheimer Research

Editor-in-Chief:

Debomoy K. Lahiri  
Department of Psychiatry
Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202
USA

Back

Alzheimers Disease Drug Development in 2008 and Beyond: Problems and Opportunities

Volume:5   Issue:4
Pp: 346-357
Robert E. Becker and Nigel H. Greig
DOI: 10.2174/156720508785132299

Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study

Volume:5   Issue:4
Pp: 358-366
Stefan S. Kassner, Gabriel A. Bonaterra, Elmar Kaiser, Wulf Hildebrandt, Jurgen Metz, Johannes Schroder and Ralf Kinscherf
DOI: 10.2174/156720508785132253

Neurosteroids and Sporadic Alzheimers Disease

Volume:5   Issue:4
Pp: 367-374
Guy Barry and Ian L. Ross
DOI: 10.2174/156720508785132325

Mechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies

Volume:5   Issue:4
Pp: 375-384
Alejandra del C. Alonso, Ben Li, Inge Grundke-Iqbal and Khalid Iqbal
DOI: 10.2174/156720508785132307

An Increase in Aβ42 in the Prefrontal Cortex is Associated with a Reversal-Learning Impairment in Alzheimers Disease Model Tg2576 APPsw Mice

Volume:5   Issue:4
Pp: 385-391
Jia-Min Zhuo, Annamalai Prakasam, Melissa E. Murray, Hai-Yan Zhang, Mark G. Baxter, Kumar Sambamurti and Michelle M. Nicolle
DOI: 10.2174/156720508785132280

Structural Changes in Alzheimers Disease Brain Microvessels

Volume:5   Issue:4
Pp: 392-395
Alexander Christov, J. Ottman, L. Hamdheydari and Paula Grammas
DOI: 10.2174/156720508785132334

Clinico-Pathologic Function of Cerebral ABC Transporters – Implications for the Pathogenesis of Alzheimers Disease

Volume:5   Issue:4
Pp: 396-405
Jens Pahnke, Olaf Wolkenhauer, Markus Krohn and Lary C. Walker
DOI: 10.2174/156720508785132262

GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data

Volume:5   Issue:4
Pp: 406-415
Sandrine Andrieu, Pierre-Jean Ousset, Nicola Coley, Mehemed Ouzid, Helene Mathiex-Fortunet and Bruno Vellas
DOI: 10.2174/156720508785132271

Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort

Volume:5   Issue:4
Pp: 416-421
D. Larry Sparks, Richard J. Kryscio, Marwan N. Sabbagh, Donald J. Connor, Lisa M. Sparks and Carolyn Liebsack
DOI: 10.2174/156720508785132316